Healthy Skepticism Library item: 5537

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

Re: the promotion of Diodoquin (iodoquinol) and Lomotil (diphenoxylate/atropine)
1993 Mar

Abstract:

Although Searle promised to send MaLAM a detailed letter about the usefulness of iodoquinol in August 1991 such a letter has not been forthcoming. Searle continues to promote Lomotil for children as young as age 2 in the Philippines despite conclusions from the World Health Organization that this product should not be used in children.

Keywords:
*analysis/Philippines/developing countries/quality of information/iodoquinol/Diodoquin/Lomotil/diphenoxylate/Searle/quality of information/WHO/World Health Organization/MaLAM/Medical Lobby for Appropriate Marketing/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES